Citation Impact
Citing Papers
Sexual selection by female immunity against paternal antigens can fix loss of function alleles
2011
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
2009 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation
2016
Achieving Donor-Specific Hyporesponsiveness Is Associated with FOXP3+ Regulatory T Cell Recruitment in Human Renal Allograft Infiltrates
2007
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
The Survival Benefit of Liver Transplantation
2005 Standout
SUBCLINICAL REJECTION AND BORDERLINE CHANGES IN EARLY PROTOCOL BIOPSY SPECIMENS AFTER RENAL TRANSPLANTATION
2004
Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts
2002
Treating hepatitis C infection in liver transplant recipients
2006
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose
2011
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
The Utility of 1- and 3-Month Protocol Biopsies on Renal Allograft Function: A Randomized Controlled Study
2008
Glycan Evolution in Response to Collaboration, Conflict, and Constraint
2013
Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation
2016 StandoutNobel
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
2010 Standout
Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis
2006
Results from a Human Renal Allograft Tolerance Trial Evaluating T-Cell Depletion with Alemtuzumab Combined with Deoxyspergualin
2005
The utility of marginal donors in liver transplantation
2003
Hepatocellular carcinoma
2012 Standout
CD4+CD25+FOXP3+ Regulatory T Cells Increase De Novo in Kidney Transplant Patients After Immunodepletion with Campath-1H
2008
Diagnostic Tools for Monitoring Kidney Transplant Recipients
2007
Human milk oligosaccharides: Every baby needs a sugar mama
2012 Standout
The Generation of Donor-Specific CD4+CD25++CD45RA+ Naive Regulatory T Cells in Operationally Tolerant Patients After Pediatric Living-Donor Liver Transplantation
2010 StandoutNobel
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
2006 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Liver grafts from anti-hepatitis B core positive donors: A systematic review
2009
SIX-YEAR CLINICAL EFFECT OF DONOR BONE MARROW INFUSIONS IN RENAL TRANSPLANT PATIENTS1
2001
Biological roles of glycans
2016 Standout
The natural history of recurrent hepatitis C and what influences this
2008
Estimates of Early Death, Acute Liver Failure, and Long-term Mortality Among Live Liver Donors
2011
Liver Transplantation for Hepatocellular Carcinoma
2008
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
2008
Structure-based antigen design: a strategy for next generation vaccines
2008
The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: A carbohydrate of unique evolution and clinical relevance
2007
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
2006 Standout
The Significance of Subclinical Rejection and the Value of Protocol Biopsies
2006
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Prednisone‐Free Maintenance Immunosuppression—A 5‐Year Experience
2005
Medication Noncompliance and its Implications in Transplant Recipients
2007
Clinical application of sirolimus in renal transplantation: an update
2005
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Alemtuzumab (Campath 1H) Induction With Tacrolimus Monotherapy Is Safe for High Immunological Risk Renal Transplantation
2007
MELD score predicts 1-year patient survival post-orthotopic liver transplantation
2003
Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
2010 StandoutNobel
Natural History, Risk Factors, and Impact of Subclinical Rejection in Kidney Transplantation
2004
The alpha-gal story: Lessons learned from connecting the dots
2015
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management
2017 Standout
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Historical perspective of living donor liver transplantation
2008
Clinical Operational Tolerance after Kidney Transplantation
2006
Lack of Benefit of Early Protocol Biopsies in Renal Transplant Patients Receiving TAC and MMF: A Randomized Study
2007
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match*
2011 StandoutNobel
Extended-Donor Criteria Liver Allografts
2006
Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells
2017 StandoutNobel
Infrared thermography (IRT) applications for building diagnostics: A review
2014 Standout
Clinical Significance of an Early Protocol Biopsy in Living-Donor Renal Transplantation: Ten-Year Experience at a Single Center
2005
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Prevention of hepatitis C virus infection using a broad cross‐neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate
2015 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Risk of End-Stage Renal Disease Following Live Kidney Donation
2014 Standout
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
2012 Standout
Double knockout pigs deficient in N ‐glycolylneuraminic acid and G alactose α‐1,3‐G alactose reduce the humoral barrier to xenotransplantation
2013
Works of Edward A. Gray being referenced
An Analysis of Early Renal Transplant Protocol Biopsies – the High Incidence of Subclinical Tubulitis
2001
Use of Alemtuzumab and Tacrolimus Monotherapy for Cadaveric Liver Transplantation: With Particular Reference to Hepatitis C Virus
2004
Kidney transplantation with bone marrow augmentation: five-year outcomes
2001
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis1
2002
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients
2002
Immunosuppression for liver transplantation in HCV-infected patients: Mechanism-based principles
2005
Complications of right lobe living donor liver transplantation
2009
Kidney Transplantation Under a Tolerogenic Regimen of Recipient Pretreatment and Low-Dose Postoperative Immunosuppression With Subsequent Weaning
2003
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath
2005
Lessons of organ-induced tolerance learned from historical clinical experience1
2004
Functionally important glycosyltransferase gain and loss during catarrhine primate emergence
2006